Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04876417 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation (tDCS) for Post COVID-19 Fatigue
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT04876417 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 74 participants.
The verdict
NCT04876417, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the short- and long-term effects of multiple sessions of 4 mA M1 tDCS on fatigue and brain activity in recovered COVID-19 patients using established measures of perception of fatigue, performance fatigability, and cerebral glucose uptake. Our central hypothesis is that tDCS will improve fatigue short- and long-term, and thus will improve quality of life (QOL) in recovered COVID-19 patients and that these changes will be associated with alterations in brain activity.
Interventions
- DEVICE Transcranial Direct Current Stimulation
- DEVICE Sham Transcranial Direct Current Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04876417
The ClinicalTrials.gov registry entry for NCT04876417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Direct Current Stimulation is the first listed.
NCT04876417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04876417 about?
NCT04876417 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS) for Post COVID-19 Fatigue". The objective of this study is to investigate the short- and long-term effects of multiple sessions of 4 mA M1 tDCS on fatigue and brain activity in recovered COVID-19 patients using established measures of perception of fatigue, performance fatigability, and cerebral glucose uptake. Our central hyp...
What is the current status of trial NCT04876417?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-06-15. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04876417?
The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE), Sham Transcranial Direct Current Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04876417?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.